SCCM Resource Library-November Journal Club: Spotlight on Pharmacy (2023)

Video Transcription

Video Summary

In this video, three presenters discuss the findings of different research studies related to critical care pharmacy. The first presenter discusses the ACORN trial, which compared cefepime and piperacillin-tazobactam in adult patients with acute infection. The trial found no significant difference between the two drugs in terms of acute kidney injury or death. The second presenter discusses a study that compared dexmedetomidine and propofol with ketamine for adult procedural sedation. The study found that the combination of dexmedetomidine and ketamine resulted in fewer delirium and coma-free days compared to propofol and ketamine. The final presenter discusses the TRIPS trial, which looked at the use of thiamine for renal protection in septic shock. The trial found no significant difference in kidney injury between patients who received thiamine and those who received a placebo. These presentations highlight the importance of research in optimizing patient care in critical care settings.

Asset Subtitle

Pharmacology, Sepsis, 2023

Meta Tag

Content Type Webcast

Knowledge Area Pharmacology

Knowledge Area Sepsis

Knowledge Area Infection

Membership Level Select

Membership Level Professional

Tag Analgesia and Sedation

Tag Antibiotics

Tag Shock

Year 2023

Keywords

critical care pharmacy

ACORN trial

cefepime

piperacillin-tazobactam

acute kidney injury

dexmedetomidine

propofol

ketamine

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.